Summit Securities Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-816
Closed -$56K 922
2024
Q2
$56K Buy
+816
New +$56.6K 0.01% 279
2019
Q3
Sell
-45,735
Closed -$439K 438
2019
Q2
$594K Buy
+45,735
New +$587K 0.07% 185

Other funds holding ITCI